B3GALT5 and neoplasm: Interestingly, B3GALT5-AS1 overexpression effectively inhibits tumor volume and weight compared with the NC treated group, and the opposite is true after knockdown (P < 0.05, P < 0.05, P < 0.01, P < 0.01, Figures 4(c)–4(f)).